# Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer

> **NCT01598792** · PHASE1 · TERMINATED · sponsor: **University of Liverpool** · enrollment: 2 (actual)

## Conditions studied

- HPV-16 +ve Oropharyngeal Carcinoma

## Interventions

- **BIOLOGICAL:** ADXS11-001

## Key facts

- **NCT ID:** NCT01598792
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Patient 2 suffered DLT post-vaccination. The vaccine manufacturers withdrew support for the study on commercial grounds.
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598792, "Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01598792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*